For research use only. Not for therapeutic Use.
Anetumab ravtansine (BAY 94-9343) is an antibody-drug conjugate (ADC) composed of a human anti-mesothelin antibody and a cytotoxic maytansinoid tubulin inhibitor DM4. Anetumab ravtansine has the potential to treat advanced solid tumors.
| Catalog Number | I047009 |
| Purity | ≥95% |
| Reference | [1] Golfier S, et al. Mol Cancer Ther (2014) 13 (6): 1537–1548. |
